CBD

“Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action“ by Roger Pertwee (2012) – This comprehensive review paper discusses the pharmacological properties and potential therapeutic applications of CBD, highlighting its diverse effects on various physiological systems.

“Cannabidiol as a Potential Treatment for Anxiety Disorders“ by Esther M. Blessing, Maria M. Steenkamp, Jorge Manzanares, and Charles R. Marmar (2015) – This review article summarizes preclinical and clinical evidence supporting the anxiolytic effects of CBD, suggesting its potential as a novel treatment for anxiety disorders.

“Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders“ by Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt, Jose Martinez-Orgado, Philip J. Robson, Brian G. Rohrback, Elizabeth Thiele, Benjamin Whalley, and Daniel Friedman (2014) – This article provides a comprehensive overview of the pharmacology of CBD and its potential therapeutic applications, with a focus on epilepsy and other neuropsychiatric disorders.

VitalPoint Technologies, Inc.

Disclaimer

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.

Scroll to Top